265 related articles for article (PubMed ID: 26429564)
1. Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis.
Roger C; Nucci B; Louart B; Friggeri A; Knani H; Evrard A; Lavigne JP; Allaouchiche B; Lefrant JY; Roberts JA; Muller L
J Antimicrob Chemother; 2016 Jan; 71(1):208-12. PubMed ID: 26429564
[TBL] [Abstract][Full Text] [Related]
2. Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations.
Roger C; Nucci B; Molinari N; Bastide S; Saissi G; Pradel G; Barbar S; Aubert C; Lloret S; Elotmani L; Polge A; Lefrant JY; Roberts JA; Muller L
Int J Antimicrob Agents; 2015 Jul; 46(1):21-7. PubMed ID: 25857948
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
[TBL] [Abstract][Full Text] [Related]
5. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
7. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
[TBL] [Abstract][Full Text] [Related]
8. Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize
Boidin C; Bourguignon L; Cohen S; Roger C; Lefrant JY; Roberts JA; Allaouchiche B; Lepape A; Friggeri A; Goutelle S
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481443
[TBL] [Abstract][Full Text] [Related]
9. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
[TBL] [Abstract][Full Text] [Related]
11. Use of 4-mg/kg/24-hour empiric aminoglycoside dosing in preoperative neonates with congenital heart disease.
Moffett BS; Rossano JW
Ann Pharmacother; 2012 Sep; 46(9):1193-7. PubMed ID: 22911340
[TBL] [Abstract][Full Text] [Related]
12. PK/PD targets of amikacin and gentamicin in ICU patients.
Coste A; Deslandes G; Jalin L; Corvec S; Caillon J; Boutoille D; Grégoire M; Bretonnière C
Med Mal Infect; 2020 Nov; 50(8):709-714. PubMed ID: 31883736
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the National French recommendations regarding the dosing regimen of 8mg/kg of gentamicin in patients hospitalised in intensive care units.
Allou N; Allyn J; Levy Y; Bouteau A; Caujolle M; Delmas B; Valance D; Brulliard C; Martinet O; Vandroux D; Montravers P; Augustin P
Anaesth Crit Care Pain Med; 2016 Oct; 35(5):331-335. PubMed ID: 27133236
[TBL] [Abstract][Full Text] [Related]
15. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
Lugo G; Castañeda-Hernández G
Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600
[TBL] [Abstract][Full Text] [Related]
16. Optimal Amikacin Levels for Patients with Sepsis in Intensive Care Unit of Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Aliska G; Setiabudy R; Purwantyastuti P; Karuniawati A; Sedono R; Dewi TU; Azwar MK
Acta Med Indones; 2017 Jul; 49(3):227-235. PubMed ID: 29093233
[TBL] [Abstract][Full Text] [Related]
17. Improving peak concentrations of a single dose regime of gentamicin in patients with sepsis in the emergency department.
Cobussen M; Stassen PM; Posthouwer D; van Tiel FH; Savelkoul PHM; Havenith T; Haeseker MB
PLoS One; 2019; 14(1):e0210012. PubMed ID: 30668571
[TBL] [Abstract][Full Text] [Related]
18. Aminoglycosides in critically ill patients: which dosing regimens for which pathogens?
Marsot A; Hraiech S; Cassir N; Daviet F; Parzy G; Blin O; Papazian L; Guilhaumou R
Int J Antimicrob Agents; 2020 Oct; 56(4):106124. PubMed ID: 32739478
[TBL] [Abstract][Full Text] [Related]
19. Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia.
Panidis D; Markantonis SL; Boutzouka E; Karatzas S; Baltopoulos G
Chest; 2005 Aug; 128(2):545-52. PubMed ID: 16100136
[TBL] [Abstract][Full Text] [Related]
20. Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis.
De Winter S; van Hest R; Dreesen E; Annaert P; Wauters J; Meersseman W; Van den Eede N; Desmet S; Verelst S; Vanbrabant P; Peetermans W; Spriet I
Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):653-663. PubMed ID: 34297338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
